They seem to have been saying for some time now that they are no longer interested in the small fee for access type deals of the past, the largest being $2 million for the Genentech extension a few years back. If that is true then this should be a major development. Either a significant financial windfall or a collaboration with a major like Sarepta? Can only dream but the right deal could get this to 8c + just as an initial point imo
PYC Price at posting:
4.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)